skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Classification of sensitizing and irritative potential in a combined in-vitro assay

Journal Article · · Toxicology and Applied Pharmacology
 [1]; ;  [1];  [2];  [3];  [4];  [1]
  1. Institute of Clinical Pharmacology and Toxicology, Charite, Berlin (Germany)
  2. Bundeswehr Hospital, Department of Internal Medicine, Berlin (Germany)
  3. Institute of Molecular Biology and Bioinformatics, Charite, Berlin (Germany)
  4. Department of Dermatology and Allergy, Charite, Berlin (Germany)

We have developed a coculture system which in parallel indicates the sensitizing and irritative potential of xenobiotics. The assay is named loose-fit coculture-based sensitization assay (LCSA) and may be performed within 5 days. The system is composed of human monocytes that differentiate to a kind of dendritic cells by 2-day culturing in the presence of allogenic keratinocytes. The culture medium is enriched by a cocktail of recombinant cytokines. On day 3, concentration series of probes are added. On day 5, cells are harvested and analyzed for expression range of CD86 as a marker of sensitizing potential and for uptake of the viability stain 7-AAD as a marker of irritative potential. Estimation of the concentration required to cause a half-maximal increase in CD86 expression allowed quantification of sensitizing potential, and estimation of the concentration required to reduce viability to 50% allowed quantification of irritative potential. Examination of substances with known potential resulted in categorization of test scores. To evaluate our data, we have compared results with those of the validated animal-based sensitization test, the murine local lymph node assay (LLNA, OECD TG 429). To a large extent, results from LCSA and from LLNA achieved analogous grouping of allergens into categories like weak-moderate-strong. However, the new assay showed an improved capacity to distinguish sensitizers from non-sensitizers and irritants. In conclusion, the LCSA contains potential to fulfil the requirements of the EU's programme for the safety of chemicals 'Registration, Evaluation, Authorisation and Restriction of chemical substances' (REACH, 2006) to replace animal models.

OSTI ID:
21460166
Journal Information:
Toxicology and Applied Pharmacology, Vol. 245, Issue 2; Other Information: DOI: 10.1016/j.taap.2010.02.019; PII: S0041-008X(10)00088-8; Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

The cytokine-dependent MUTZ-3 cell line as an in vitro model for the screening of contact sensitizers
Journal Article · Sat Apr 01 00:00:00 EST 2006 · Toxicology and Applied Pharmacology · OSTI ID:21460166

An epidermal equivalent assay for identification and ranking potency of contact sensitizers
Journal Article · Tue Oct 15 00:00:00 EDT 2013 · Toxicology and Applied Pharmacology · OSTI ID:21460166

Assessment of the U937 cell line for the detection of contact allergens
Journal Article · Sun Apr 15 00:00:00 EDT 2007 · Toxicology and Applied Pharmacology · OSTI ID:21460166